1 Study Coverage
    1.1 Betahistine Product Introduction
    1.2 Market by Type
        1.2.1 Global Betahistine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 8mg
        1.2.3 25mg
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Betahistine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cerebral Thrombosis
        1.3.3 Cerebral Embolism
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Betahistine Sales Estimates and Forecasts 2017-2028
    2.2 Global Betahistine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Betahistine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Betahistine Sales by Region
        2.4.1 Global Betahistine Sales by Region (2017-2022)
        2.4.2 Global Sales Betahistine by Region (2023-2028)
    2.5 Global Betahistine Revenue by Region
        2.5.1 Global Betahistine Revenue by Region (2017-2022)
        2.5.2 Global Betahistine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Betahistine Sales by Manufacturers
        3.1.1 Global Top Betahistine Manufacturers by Sales (2017-2022)
        3.1.2 Global Betahistine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Betahistine in 2021
    3.2 Global Betahistine Revenue by Manufacturers
        3.2.1 Global Betahistine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Betahistine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Betahistine Revenue in 2021
    3.3 Global Betahistine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Betahistine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Betahistine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Betahistine Sales by Type
        4.1.1 Global Betahistine Historical Sales by Type (2017-2022)
        4.1.2 Global Betahistine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Betahistine Sales Market Share by Type (2017-2028)
    4.2 Global Betahistine Revenue by Type
        4.2.1 Global Betahistine Historical Revenue by Type (2017-2022)
        4.2.2 Global Betahistine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Betahistine Revenue Market Share by Type (2017-2028)
    4.3 Global Betahistine Price by Type
        4.3.1 Global Betahistine Price by Type (2017-2022)
        4.3.2 Global Betahistine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Betahistine Sales by Application
        5.1.1 Global Betahistine Historical Sales by Application (2017-2022)
        5.1.2 Global Betahistine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Betahistine Sales Market Share by Application (2017-2028)
    5.2 Global Betahistine Revenue by Application
        5.2.1 Global Betahistine Historical Revenue by Application (2017-2022)
        5.2.2 Global Betahistine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Betahistine Revenue Market Share by Application (2017-2028)
    5.3 Global Betahistine Price by Application
        5.3.1 Global Betahistine Price by Application (2017-2022)
        5.3.2 Global Betahistine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Betahistine Market Size by Type
        6.1.1 North America Betahistine Sales by Type (2017-2028)
        6.1.2 North America Betahistine Revenue by Type (2017-2028)
    6.2 North America Betahistine Market Size by Application
        6.2.1 North America Betahistine Sales by Application (2017-2028)
        6.2.2 North America Betahistine Revenue by Application (2017-2028)
    6.3 North America Betahistine Market Size by Country
        6.3.1 North America Betahistine Sales by Country (2017-2028)
        6.3.2 North America Betahistine Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Betahistine Market Size by Type
        7.1.1 Europe Betahistine Sales by Type (2017-2028)
        7.1.2 Europe Betahistine Revenue by Type (2017-2028)
    7.2 Europe Betahistine Market Size by Application
        7.2.1 Europe Betahistine Sales by Application (2017-2028)
        7.2.2 Europe Betahistine Revenue by Application (2017-2028)
    7.3 Europe Betahistine Market Size by Country
        7.3.1 Europe Betahistine Sales by Country (2017-2028)
        7.3.2 Europe Betahistine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Betahistine Market Size by Type
        8.1.1 Asia Pacific Betahistine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Betahistine Revenue by Type (2017-2028)
    8.2 Asia Pacific Betahistine Market Size by Application
        8.2.1 Asia Pacific Betahistine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Betahistine Revenue by Application (2017-2028)
    8.3 Asia Pacific Betahistine Market Size by Region
        8.3.1 Asia Pacific Betahistine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Betahistine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Betahistine Market Size by Type
        9.1.1 Latin America Betahistine Sales by Type (2017-2028)
        9.1.2 Latin America Betahistine Revenue by Type (2017-2028)
    9.2 Latin America Betahistine Market Size by Application
        9.2.1 Latin America Betahistine Sales by Application (2017-2028)
        9.2.2 Latin America Betahistine Revenue by Application (2017-2028)
    9.3 Latin America Betahistine Market Size by Country
        9.3.1 Latin America Betahistine Sales by Country (2017-2028)
        9.3.2 Latin America Betahistine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Betahistine Market Size by Type
        10.1.1 Middle East and Africa Betahistine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Betahistine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Betahistine Market Size by Application
        10.2.1 Middle East and Africa Betahistine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Betahistine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Betahistine Market Size by Country
        10.3.1 Middle East and Africa Betahistine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Betahistine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 TOWA PHARMACEUTICAL CO., LTD
        11.1.1 TOWA PHARMACEUTICAL CO., LTD Corporation Information
        11.1.2 TOWA PHARMACEUTICAL CO., LTD Overview
        11.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Developments
    11.2 Nichi-Iko Pharmaceutical
        11.2.1 Nichi-Iko Pharmaceutical Corporation Information
        11.2.2 Nichi-Iko Pharmaceutical Overview
        11.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Nichi-Iko Pharmaceutical Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Nichi-Iko Pharmaceutical Recent Developments
    11.3 Takeda Pharmaceutical Company Limited
        11.3.1 Takeda Pharmaceutical Company Limited Corporation Information
        11.3.2 Takeda Pharmaceutical Company Limited Overview
        11.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Takeda Pharmaceutical Company Limited Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Takeda Pharmaceutical Company Limited Recent Developments
    11.4 EA Pharma Co., Ltd.
        11.4.1 EA Pharma Co., Ltd. Corporation Information
        11.4.2 EA Pharma Co., Ltd. Overview
        11.4.3 EA Pharma Co., Ltd. Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 EA Pharma Co., Ltd. Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 EA Pharma Co., Ltd. Recent Developments
    11.5 Disphar International B.V.
        11.5.1 Disphar International B.V. Corporation Information
        11.5.2 Disphar International B.V. Overview
        11.5.3 Disphar International B.V. Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Disphar International B.V. Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Disphar International B.V. Recent Developments
    11.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
        11.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information
        11.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Overview
        11.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments
    11.7 DOC Generici
        11.7.1 DOC Generici Corporation Information
        11.7.2 DOC Generici Overview
        11.7.3 DOC Generici Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 DOC Generici Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 DOC Generici Recent Developments
    11.8 Ciclum Farma Unipessoal
        11.8.1 Ciclum Farma Unipessoal Corporation Information
        11.8.2 Ciclum Farma Unipessoal Overview
        11.8.3 Ciclum Farma Unipessoal Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Ciclum Farma Unipessoal Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Ciclum Farma Unipessoal Recent Developments
    11.9 Mylan
        11.9.1 Mylan Corporation Information
        11.9.2 Mylan Overview
        11.9.3 Mylan Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Mylan Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Mylan Recent Developments
    11.10 Orion Corporation
        11.10.1 Orion Corporation Corporation Information
        11.10.2 Orion Corporation Overview
        11.10.3 Orion Corporation Betahistine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Orion Corporation Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Orion Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Betahistine Industry Chain Analysis
    12.2 Betahistine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Betahistine Production Mode & Process
    12.4 Betahistine Sales and Marketing
        12.4.1 Betahistine Sales Channels
        12.4.2 Betahistine Distributors
    12.5 Betahistine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Betahistine Industry Trends
    13.2 Betahistine Market Drivers
    13.3 Betahistine Market Challenges
    13.4 Betahistine Market Restraints
14 Key Findings in The Global Betahistine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Betahistine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 8mg
    Table 3. Major Manufacturers of 25mg
    Table 4. Major Manufacturers of Others
    Table 5. Global Betahistine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Betahistine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Betahistine Sales by Region (2017-2022) & (K Units)
    Table 8. Global Betahistine Sales Market Share by Region (2017-2022)
    Table 9. Global Betahistine Sales by Region (2023-2028) & (K Units)
    Table 10. Global Betahistine Sales Market Share by Region (2023-2028)
    Table 11. Global Betahistine Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Betahistine Revenue Market Share by Region (2017-2022)
    Table 13. Global Betahistine Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Betahistine Revenue Market Share by Region (2023-2028)
    Table 15. Global Betahistine Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Betahistine Sales Share by Manufacturers (2017-2022)
    Table 17. Global Betahistine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Betahistine Revenue Share by Manufacturers (2017-2022)
    Table 19. Betahistine Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Betahistine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Betahistine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Betahistine as of 2021)
    Table 22. Betahistine Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Betahistine Product Offered
    Table 24. Date of Manufacturers Enter into Betahistine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Betahistine Sales by Type (2017-2022) & (K Units)
    Table 27. Global Betahistine Sales by Type (2023-2028) & (K Units)
    Table 28. Global Betahistine Sales Share by Type (2017-2022)
    Table 29. Global Betahistine Sales Share by Type (2023-2028)
    Table 30. Global Betahistine Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Betahistine Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Betahistine Revenue Share by Type (2017-2022)
    Table 33. Global Betahistine Revenue Share by Type (2023-2028)
    Table 34. Betahistine Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Betahistine Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Betahistine Sales by Application (2017-2022) & (K Units)
    Table 37. Global Betahistine Sales by Application (2023-2028) & (K Units)
    Table 38. Global Betahistine Sales Share by Application (2017-2022)
    Table 39. Global Betahistine Sales Share by Application (2023-2028)
    Table 40. Global Betahistine Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Betahistine Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Betahistine Revenue Share by Application (2017-2022)
    Table 43. Global Betahistine Revenue Share by Application (2023-2028)
    Table 44. Betahistine Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Betahistine Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Betahistine Sales by Type (2017-2022) & (K Units)
    Table 47. North America Betahistine Sales by Type (2023-2028) & (K Units)
    Table 48. North America Betahistine Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Betahistine Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Betahistine Sales by Application (2017-2022) & (K Units)
    Table 51. North America Betahistine Sales by Application (2023-2028) & (K Units)
    Table 52. North America Betahistine Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Betahistine Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Betahistine Sales by Country (2017-2022) & (K Units)
    Table 55. North America Betahistine Sales by Country (2023-2028) & (K Units)
    Table 56. North America Betahistine Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Betahistine Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Betahistine Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Betahistine Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Betahistine Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Betahistine Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Betahistine Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Betahistine Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Betahistine Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Betahistine Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Betahistine Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Betahistine Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Betahistine Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Betahistine Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Betahistine Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Betahistine Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Betahistine Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Betahistine Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Betahistine Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Betahistine Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Betahistine Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Betahistine Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Betahistine Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Betahistine Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Betahistine Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Betahistine Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Betahistine Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Betahistine Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Betahistine Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Betahistine Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Betahistine Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Betahistine Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Betahistine Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Betahistine Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Betahistine Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Betahistine Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Betahistine Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Betahistine Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Betahistine Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Betahistine Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Betahistine Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Betahistine Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Betahistine Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Betahistine Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Betahistine Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Betahistine Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Betahistine Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Betahistine Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Betahistine Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Betahistine Revenue by Country (2023-2028) & (US$ Million)
    Table 106. TOWA PHARMACEUTICAL CO., LTD Corporation Information
    Table 107. TOWA PHARMACEUTICAL CO., LTD Description and Major Businesses
    Table 108. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. TOWA PHARMACEUTICAL CO., LTD Recent Developments
    Table 111. Nichi-Iko Pharmaceutical Corporation Information
    Table 112. Nichi-Iko Pharmaceutical Description and Major Businesses
    Table 113. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. Nichi-Iko Pharmaceutical Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Nichi-Iko Pharmaceutical Recent Developments
    Table 116. Takeda Pharmaceutical Company Limited Corporation Information
    Table 117. Takeda Pharmaceutical Company Limited Description and Major Businesses
    Table 118. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Takeda Pharmaceutical Company Limited Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Takeda Pharmaceutical Company Limited Recent Developments
    Table 121. EA Pharma Co., Ltd. Corporation Information
    Table 122. EA Pharma Co., Ltd. Description and Major Businesses
    Table 123. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. EA Pharma Co., Ltd. Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. EA Pharma Co., Ltd. Recent Developments
    Table 126. Disphar International B.V. Corporation Information
    Table 127. Disphar International B.V. Description and Major Businesses
    Table 128. Disphar International B.V. Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. Disphar International B.V. Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Disphar International B.V. Recent Developments
    Table 131. HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information
    Table 132. HENNIG ARZNEIMITTEL GmbH & Co. KG Description and Major Businesses
    Table 133. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments
    Table 136. DOC Generici Corporation Information
    Table 137. DOC Generici Description and Major Businesses
    Table 138. DOC Generici Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 139. DOC Generici Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. DOC Generici Recent Developments
    Table 141. Ciclum Farma Unipessoal Corporation Information
    Table 142. Ciclum Farma Unipessoal Description and Major Businesses
    Table 143. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 144. Ciclum Farma Unipessoal Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Ciclum Farma Unipessoal Recent Developments
    Table 146. Mylan Corporation Information
    Table 147. Mylan Description and Major Businesses
    Table 148. Mylan Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 149. Mylan Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Mylan Recent Developments
    Table 151. Orion Corporation Corporation Information
    Table 152. Orion Corporation Description and Major Businesses
    Table 153. Orion Corporation Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 154. Orion Corporation Betahistine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Orion Corporation Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Betahistine Distributors List
    Table 159. Betahistine Customers List
    Table 160. Betahistine Market Trends
    Table 161. Betahistine Market Drivers
    Table 162. Betahistine Market Challenges
    Table 163. Betahistine Market Restraints
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Betahistine Product Picture
    Figure 3. Global Betahistine Market Share by Type in 2021 & 2028
    Figure 3. 8mg Product Picture
    Figure 4. 25mg Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Betahistine Market Share by Application in 2021 & 2028
    Figure 7. Cerebral Thrombosis
    Figure 8. Cerebral Embolism
    Figure 9. Others
    Figure 10. Betahistine Report Years Considered
    Figure 11. Global Betahistine Sales 2017-2028 (K Units)
    Figure 12. Global Betahistine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Betahistine Revenue 2017-2028 (US$ Million)
    Figure 14. Global Betahistine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Betahistine Sales Market Share by Region (2017-2022)
    Figure 16. Global Betahistine Sales Market Share by Region (2023-2028)
    Figure 17. North America Betahistine Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Betahistine Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Betahistine Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Betahistine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Betahistine Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Betahistine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Betahistine Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Betahistine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Betahistine Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Betahistine Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Betahistine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Betahistine in the World: Market Share by Betahistine Revenue in 2021
    Figure 29. Global Betahistine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Betahistine Sales Market Share by Type (2017-2028)
    Figure 31. Global Betahistine Revenue Market Share by Type (2017-2028)
    Figure 32. Global Betahistine Sales Market Share by Application (2017-2028)
    Figure 33. Global Betahistine Revenue Market Share by Application (2017-2028)
    Figure 34. North America Betahistine Sales Market Share by Type (2017-2028)
    Figure 35. North America Betahistine Revenue Market Share by Type (2017-2028)
    Figure 36. North America Betahistine Sales Market Share by Application (2017-2028)
    Figure 37. North America Betahistine Revenue Market Share by Application (2017-2028)
    Figure 38. North America Betahistine Sales Share by Country (2017-2028)
    Figure 39. North America Betahistine Revenue Share by Country (2017-2028)
    Figure 40. United States Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Betahistine Sales Market Share by Type (2017-2028)
    Figure 43. Europe Betahistine Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Betahistine Sales Market Share by Application (2017-2028)
    Figure 45. Europe Betahistine Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Betahistine Sales Share by Country (2017-2028)
    Figure 47. Europe Betahistine Revenue Share by Country (2017-2028)
    Figure 48. Germany Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 49. France Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Betahistine Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Betahistine Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Betahistine Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Betahistine Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Betahistine Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Betahistine Revenue Share by Region (2017-2028)
    Figure 59. China Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 62. India Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 64. China Taiwan Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Betahistine Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Betahistine Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Betahistine Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Betahistine Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Betahistine Sales Share by Country (2017-2028)
    Figure 73. Latin America Betahistine Revenue Share by Country (2017-2028)
    Figure 74. Mexico Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Betahistine Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Betahistine Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Betahistine Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Betahistine Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Betahistine Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Betahistine Revenue Share by Country (2017-2028)
    Figure 83. Turkey Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Betahistine Revenue (2017-2028) & (US$ Million)
    Figure 86. Betahistine Value Chain
    Figure 87. Betahistine Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed